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Increased vascular permeability in rabbits may be produced by a variety of immuno- 
logicalmechanisms. One of these has been shown to require complement, platelets, and 
neutrophils and could be demonstrated by the passive cutaneous anaphylaxis (PCA) 
reaction (1, 2). Histamine was shown to participate in this reaction, and both it and 
serotonin have been implicated in other inflammatory conditions of immunological 
origin (3, 4). 
One of the major reservoirs of histamine in the rabbit is the platelet, and since these 
cells are known to release their histamine in the presence of immunological reactions in 
vitro (5-9) they may play an important part in the production of increased  vascular 
permeability. In vitro histamine release from platelets by antigen and antibody re- 
quires the presence of plasma (5, 10, 11). The precise plasma constituents which are 
necessary are unknown, and although the complement system has been implicated (5, 
11), evidence presented by Barbaro (10) suggested only a partial involvement. Most of 
these experiments on the release process have involved soluble antigens. 
Another way in which antigen-antibody complexes react with platelets is through 
the production of adherence reactions with the mediation of complement ((2) (12, 13). 
The process has been shown to require the participation of C3 (13), thus resembling the 
immune adherence reaction with primate erythrocytes. Only platelets from certain 
species undergo this adherence reaction (13), but both soluble and particulate antigens 
may be employed. 
The  studies  reported here were undertaken  to  examine the  antibody that 
induces complement-dependent PCA reactions (1) for its ability to react with 
platelets in vitro.  Since the in vivo lesions were inhibited  by depletion  of C3 
with cobra venom factor, the role of complement in the reactions was of partic- 
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ular  interest.  An  examination  of  the  adherence  reactions  of  platelets  in  the 
light of the histamine-releasing processes was also undertaken  and has demon- 
strated  at least two mechanisms of histamine release. 
Materials and Metkods 
D//uent.--Tyrode's solution containing 0.25% gelatin was used for all the release reactions. 
Platelets were washed, however, in Tyrode's solution with gelatin from which the calcium and 
magnesium chloride had been omitted. 
EDTA  and EGTA.--The  disodium and  tetrasodium  salts of ethylenediaminetetra,xcetic 
acid were prepared as 0.2 ~  solutions and mixed to give a pH of 7.4. Ethylene glycol bis(~- 
aminoethyl ether) N,Nt-tetraacetic acid (EGTA) (K & K Laboratories Inc., Plainview, N. Y.) 
was prepared  as a  0.2 M solution and neutralized with NaOH. These stock solutions were 
diluted before use. 
Antig~n.--Bovine serum albumin (BSA)  (Armour Pharmaceutical Co., Ill.). 
Antisara.--Rabbit anti-BSA antiserum was stimulated by injection of BSA in incomplete 
Freund's adjuvant. The antiserum produced after 2-4 wk was separated on diethylaminoethyl 
(DEAE) cellulose,  and the fraction not adherent in 0.01 ~  sodium phosphate buffer, pH 8.1, 
was concentrated  and  frozen. This antibody preparation  had  complement-dependent  PCA 
activity. In addition, antisera prepared and fractionated by methods described in the previous 
paper  (1) were also employed. Quantitative precipitation  (14) with the antigen was used to 
determine the concentration of precipitable antibody nitrogen. 
Rabbits.--Adult  New Zealand white rabbits were employed as a  source of platelets and 
plasma. C6-deficient rabbits were obtained by breeding a homozygous male (which was kindly 
supplied by Dr. C. Biro of Mexico City) with New Zealand females and then with the hetero- 
zygotes produced. It was possible,  therefore, to compare homozygous and heterozygous ani- 
mals. 
Plalelets and Plasma.--Silicorfized glassware was used throughout. Blood was obtained from 
the heart or ear artery and immediately mixed with 1:10 vol of 0.2 M EDTA. Platelet-rich 
plasma was aspirated  after centrifugation in the cold (220 g for 20 rain). The platelets and 
plasma were separated  (1400 g for 20 rain) and the platelets were resuspended in Tyrode's 
solution without Ca  ++ or Mg  ++ containing 0.005 ~ EDTA, and then washed twice and kept at 
4°C in Tyrode's solution without Ca++ or Mg++. The suspension  was standardized to 5 X  108 
platelets/ml. 
Immediately before use,  the plasma calcium and magnesium were restored by the addition 
of 1:10 vol of a mixture of 2% CaC12 and 2% MgC12. To prevent clotting, 10 tmits/ml heparin 
was included. 
C3 Preparation.--Rabbit  C3 was prepared from 1 liter rabbit serum by the method described 
for human C3 (15). Following euglobulin separation and DEAE cellulose chromatography the 
fraction rich in C3  (as detected by precipitation with anti-C3 in agar) was fractionated on a 
column of hydroxylapatite. The fraction eluted with buffer of 14.5 mmho conductivity con- 
rained the C3. After concentration the preparation  contained 0.5  mg protein/ml. Immune 
adherence was given by EAC1, 4, 2 plus 0.5/~g of this preparation. It was contaminated with 
some ~,-globulin  (Ouchterlony analysis), C5 and C6. C5 activity was detected by adding the 
preparation  to EACI, 4,  2  and  measuring the hemolysis produced by a  guinea pig reagent 
containing the components C6-C9, which was kindly supplied by Dr. N. Cooper. C6 was as- 
sayed by adding the preparation to a mixture of EA and 0.1 ml C6-deficient rabbit serum and 
measuring the hemolysis produced. In this test system for C6, 50% hemolysis was produced 
by 10/~g of the preparation. 
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restored,  another preparation  was used with which 50% hemolysis in the presence of C6- 
deficient serum was produced by a 1:225 dilution (12/~g). 
PreparaH~m of Anapkylatoxi~.--Whole  rabbit serum was fractionated on triethylamino- 
ethyl (TEAE) cellulose. After applying the serum in 0.03 ~ sodium phosphate buffer, pH 8.1, 
and removing the nonadherent proteins, a linear salt and pH gradient using 0.2 ~  NaH~.PO4 
was applied. The tubes containing C3 were pooled and concentrated. These fractions were also 
found to contain the E-globulin proinactivator of cobra venom factor (CoF), as well as C5 and 
other E-globulins.  Anaphylatoxin was generated from this preparation with CoF (25 units/rag 
protein N) by incubation for 30 vain at M°C with 7.5 X  10  ~  M CaC12 and 2.5 X  10  .4 ~  MgC12. 
The anaphylatoxin was further purified by gel filtration on Sephadex G-100 in acetate buffered 
saline at pH 4.0. The active fraction was assayed on the guinea pig ileum and on isolated rat 
peritoneal mast cells after restoration to neutrality. 
Rat anaphylatoxin was produced by CoF treatment of whole rat serum and was separated 
on Sephadex G-100 as deson'ved above. 
EAC1, 4, 2 and Immune Adher~e.--Rabbit antiserum was used to sensitize the erythro- 
cytes and the procedures used were those described by Linsoott and Cochrane (16). EACI, 4, 2 
was prepared with guinea pig serum at 0°C. 
Zymosan.--After  boiling  and  thorough  washing,  the zymosan  (Nutrional  Biochemical 
Corp., Cleveland, Ohio) was resuspended  to a  concentration  of 2.5 X  109  particles/ml  (35 
mg/ml). The zymosan was incubated for 15 to 30  rain with plasma  (1  X  109  particles/ml 
plasma) and  then washed five times. 
Pla~n~ Absorption and Depletion.--Plasma was absorbed with antigen-antibody precipitates 
(100/~g antibody N/ml plasma) prepared at equivalence for 30 rain at 37°C. 
Plasma C3 was inactivated by treatment with 80 units cobra venom factor (CoF)/ml for 
15 mill at 37°C. The preparation of CoF and the depletion of C3 in vivo has been described 
previously (1). 1 unit represents that amount which reduces the hemolysis produced by 1:20 
dilution of human serum to 50%. 
Platelet Histamine Rde~se.--The total reaction volume was 2.5 ml. Zymosan and alexinated 
erythrocytes (2.5 X  l0  s particles or cells) were allowed to react with 2.5 X  l0  s platelets for 30 
min at 37°C with shaking. For tests with soluble antigen, the diluent, antigen, 0.25 ml plasma 
(10%), platelets, and antibody were added together in that order and also incubated for 30 
rain at 37°C. Samples were examined microscopically after 10 to 15 rain. After the incubation 
period the tubes were centrifuged and  the supernatant  fluid was assayed for its content of 
histamine on the atropiuized guinea pig ileum. The sediment was boiled for 2 min in distilled 
water and also assayed, so that the released histamine could be expressed as a percentage. The 
background  release observed by incubation of platelets alone or platelets with any two of the 
three reactants  varied from 3  to  10%  and  this background  has been subtracted  from the 
reported percentages. 
RESULTS 
H~stamine Release  from Platelets Induc~ by Complement-Dependent 
PCA Antibody 
Clumping and Histamine Release from Platelets in the Presence of Plasma.-- 
Rabbit anti-BSA antibody capable of inducing complement-dependent passive 
cutaneous anaphylaxis (1)  (C-dep PCA antibody) was added to a suspension 
of washed rabbit  platelets in  the presence of antigen and normal plasma. 
Under these circumstances, microscopic examination of the platelet suspension 
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of incubation if all four constituents (antigen, antibody, plasma, and platelets) 
were included, but was absent if any of the four was omitted. Histamine re- 
lease was also detected under conditions where the platelets clumped and after 
30 rnln incubation many of the platelets appeared to have lysed. The results of 
a typical experiment are shown at the top of Table I. 
C-dep  PCA  antibody was  fractionated by Pevikon block electrophoresis, 
column chromatography, and density gradient ultracentrifugation. The frac- 
TABLE I 
Plasma Factors in Immunological Histamine Rdease from Platdets 
Antigen -t- antibody +:* 
Normal plasma  Clumping$ 
% release§ 
Phsma absorbed with Ag +  Ab 
Heated plasma (56°C, 30 min) 







C6-deficient plasma  Clumping 
% release 








* Antibody (12 ~g N) was used with 1/20 the quantity of antigen required at equivalence, 
2.5 X 10  s platelets and decreasing  volumes of plasma. 
Clumping of platelets was observed microscopically  after 15 rain. 
§ Released histamine was assayed after 30 min at 37°C. 
The depletion procedures are described  in the Materials and Methods section. 
tions were tested for their PCA activity (1) and also for their ability to induce 
histamine release from platelets in the presence of normal plasma. In all cases 
the  PCA  and histamine-releasing  activities were found together. Histamine 
release from platelets by this antigen-antibody reaction had the same proper- 
ties described previously for immunological release of histamine from rabbit 
platelets  (5-9):  the  time course of the release process at  37°C  was  similar, 
beginning at 10 min and approaching a maximum at 30 min; maximal release 
occurred in antibody excess (for 10/~g antibody N, ~o  of the antigen required 
for equivalence was optimal) and with the inclusion of 10% plasma; preincu- 
bation of antibody, antigen, and plasma before addition of platelets resulted 
in  reduced release  (as will be noted below in  Fig.  3);  and the reaction was 
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Examination  of Washed Blood Cells from Rabbits Producing Antibody for 
Histamine Release Induced by Antigen.--Blood  was obtained from four rabbits 
which were producing  homoeytotropic antibody and from four producing C- 
dep PCA antibody as evidenced by skin tests in rabbits with or without C3 
depletion (1). The cells from 1 ml of blood were washed four times with Ty- 
rode's solution containing gelatin and resuspended in this medium. Mter addi- 
tion of 5 #g BSA nitrogen and incubation for 30 mln  at 37°C, the released 
histamine was assayed.  Only blood cells from rabbits producing  homocyto- 
tropic antibody rdeased histnmlne (up to 70%)  under these circumstances. 
In confirmation of the results of Siraganian  and Oliveira  (17) and Barbaro 
and Becker  1  some histamine was released from lenkocytes alone, but if platelets 
were  also  present,  a  greatly increased  quantity of histamine  (coming from 
the platelets)  was found in the supernatant fluid. 
C-dep  PCA  antibody could  not be  shown  to bind  to blood  cells in  this 
manner in multiple tests. 
The Adherence of Plate~ets and Release of Histamine Using Particulate Anti- 
gens: a Requirement for C3.--Platelet clumping was a consistent finding of the 
in vitro histamine release from platelets described above and, as will be shown 
later, this clumping was inhibited if C3-depleted  plasma was employed. The 
following experiments were therefore undertaken to examine in detail the role 
of the platelet adherence  reaction,  in which  C3 has been implicated (13) in 
the release of histamine. The use of particulate antigens enabled the antigen- 
antibody complexes to be washed after the addition of complement  and al- 
lowed the reaction to be carried out in a plasma-free environment. Histamine 
release was therefore  measured after platelets had been allowed to adhere to 
sensitized sheep  erythrocytes or zymosan, to which complement  components 
had been fixed. 
Zymosan.--The reaction of zymosan particles with normal serum or plasma 
causes the fixation of large quantities of C3, as has been shown in many labora- 
tories. Zymosan was therefore incubated with plasma,  then washed and added 
to a suspension of washed platelets. The dose response curve of histamine re- 
lease is shown in Fig.  1. Control preparations consisted of zymosan incubated 
with plasma which  had not been  recalcified  (EDTA-plasma),  with plasma 
treated with CoF in vitro, or with plasma from CoF-treated rabbits  (CoF- 
plasma).  Such  preparations did not produce  histanfine release.  C6-deficient 
plasma on the other hand, when reacted with zymosan followed by washing, 
was fully capable  of causing histamine release.  In all cases where histamine 
release was detected, adherence of platelets to the zymosan was also observed. 
Sheep Erytkrocytes.--EAC1,4,2  was prepared with guinea pig complement 
and was then reacted with a rabbit C3 preparation. Only after the addition of~ 
the C3 was platelet adherence  observed or histamine release detected (Table 
t Barbaro, J. F., and E. L. Becker. Personal communication, 172  HISTAMINE RELEASE FRO~( RABBIT PLATELETS. II 
II).  Moreover,  a  participation  d  C6  in  the  release  by  particulate  antigens 
can be excluded by the finding that EA treated with C6-def plasma was fully 
active for histamine release. 
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FIO. 1. Dose response curve of histamine release from platelets by zymosan treated with 
plasma. 5 X  10  s zymosan particles were incubated with the different sources of plasma  (see 
text) and washed before addition of washed platelets. Histamine release was emsayed  after 30 
rain at 37°C. 
TABLE II 
Plate.let Histamine Release Induced by Washed EAC 1,4,2,3 Preparations 
Erythrocyte  preparations  Adherence of  platelets  Histamine release 
EA 
EACgp  § 1,4,2 
EACgp  § 1,4,2 +  rabbit C'3 preparation* 









* EAC 1,4,2 (2.5 X  10  s) q- C3 preparation  (40 #g protein) for 10 rain at 30°C and then 
washed. 
EA (2.5 X  108) +  0.1 ml C6-deficient plasma for 20 rain at 37°C and then washed. 
The erythrocytes were reacted with 2.5 X  108 washed rabbit platelets  for 30 rain at 37°C. 
§ gp, guinea pig complement components. 
A  possible action of C1 on the platelet  after it had adhered to the erythro- 
cyte was tested by decaying the same quantity of EAC1,4,2,3 in 0.01 ~  EDTA 
at 37°C for 1 hr and then washing before addition to the platelets.  Since the 
release was unaffected by this  treatment,  such  an activity of C1  is unlikely. 
In an attempt to see if C3 peptidase activity was involved, 1 X  10  -~ ~  glycyl- P. M. HENSON AND C. O. COCIIRANE  173 
tyrosine was included in the reacti0n mixture (EAC 1,4,2,3 or zymosan treated 
with plasma plus washed platelets), but no inhibition of release was observed. 
Another  possible  releasing  mechanism  involving  complement  is  by  the 
action of anaphylatoxins. To test this hypothesis, five times as much rabbit 
or rat  anaphylatoxin  as was required to contract the guinea pig ileum and 
release  histamine  from  rat  peritoneal  mast  cells  was  added  to  2.5  ×  l0  s 
washed rabbit platelets, with  or without added plasma.  In neither case was 
any histamine release found, 
These results indicate that as far as particulate antigens (zymosan or erythro- 
cytes)  are concerned,  platelet histamine  release requires the reaction  of C3, 
but not of C6 or complement components beyond C6 in the sequence. 
Platelet Histamine Release Using a Soluble Antigen 
Plasma Requirements for Histamine Release.--Table  I  shows the clumping 
and  histamine-releasing  effect of  dilutions  of normal  rabbit  plasma  in  the 
presence of antibody in excess, antigen (~'~0 of the amount:required at equiva- 
lence),  and washed platelets. Neither clumping nor release was observed if the 
plasma  was  previously  absorbed  with  BSA-anti-BSA,  heated at  56°C,  or 
depleted of C3 with cobra venom factor (CoF). These findings  indicated that 
the complement system was probably involved in this immunological  release 
of histamine from platelets. 
The Requirement for C6.--The results shown in Table i  indicate  that  C6- 
deficient plasma was not able to induce  histamine  release  from  platelets  in 
the presence of antigen and excess antibody. Platelet clumping,  however, was 
unaffected. Plasma from seven animals  homozygous for C6 deficiency were 
tested and found to be inactive for histamine release,  in contrast to plasma 
from seven heterozygotes which behaved normally. Addition of 0.025 ml of a 
preparation rich in rabbit C6 (but also containing C3 and some C5) restored 
the  hemolytic  activity  of  C6-deficient  plasma.  This  restored  plasma now 
behaved like normal  plasma,  i.e.,  it  supported  both  platelet  clumping  and 
histamine  release.  Histamine  release  in  this  system,  therefore,  requires  the 
action of C6. 
Reduced  Histamine  Release  Following  PreincubaHon  of  the  Immune  Com- 
plexes.--A notable and unexplained feature of the histamine release produced 
by soluble antigen,  antibody, and plasma is the decay in activity observed 
if the three components are preincubated together before addition of the plate- 
lets (Fig.  2). This was observed with antibody in excess and at equivalencei 
although  it was more marked in  the former case.  Another property of this 
in vitro reaction requiring explanation is the reduced release seen if the antigen 
and antibody are prepared at equivalence;  even though the resulting precipi- 
tates fix maximal quantities of hemolytic complement. 
In an attempt to elucidate the mechanisms responsible for these phenomena, 
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Antigen and antibody in excess were preincubated together at 37°C before 
addition of plasma and platelets. This led to a  progressive loss of histamine- 
releasing activity (Fig. 2). The loss in activity was even greater when normal 
plasma  was  also  present  during  the  preincubation,  although  this  was  not 
observed with EDTA-plasma. If plasma was preincubated by itself, its hista- 
mine-releasing properties were not markedly affected. The loss of activity due 
to preincubation of antigen and antibody in excess was slowed if the reactants 
were preincubated in larger volumes of diluent or at 0°C. 
Preincabation  of  Preincubation  of 
90.  Aatiizen,Antibody,  and Plasma  80.  Antigen and Antibody 
•  Antibody  Excess 
70  70 
.  60.  60"  \  oEquivalsnce 
j  SO,  50, 
"i  40-  ,~o, 
20-  20 
10-  10 
o  1'5  io  s'o  l's  3'o  6'o  g~ 
Minutes of Preincabation 
Fro. 2.  Hist~mlne release following preincubation of immune reactants.  Antigen, antibody, 
and plasma, or antigen and antibody alone were preincubated at 37°(2 before addition of plate- 
lets. Histamine release was assayed after a further 30 min at 37°C. Antibody (10 #g N); anti- 
gen, 0.1 gg N  (antibody excess), 2 #g N  (equivalence); plasma, 0.25  ml  (10%);  and  platelets 
(2.5 X  a0s). 
In contrast, when antigen and antibody at equivalence were preincubated, 
no reduction in releasing activity was observed, although once again some loss 
occurred if plasma was also present. 
These findings suggested that changes in  precipitate  structure with  time 
might account for some of the loss of activity and since the loss was greater 
in the presence of plasma, that generation of an inhibitor in the plasma might 
also contril~ute. 
Generation of an  Inhibitor  of Histamine  Release.--The  possibility that  an 
inhibitor  of  histamine  release  was  being  generated  was  further  examined. 
Zymosan and plasma were incubated in duplicate for different lengths of time 
at 37°C. At each time interval the zymosan and plasma in one tube were added P.  M.  HENSON  AND  C.  G.  COCHRANE  175 
to a suspension of washed platelets. The zymosan in the other tube was washed 
before being added to the platelets. Even after 90 mln (and in some experiments 
2 hr), the washed zymosan with complement on (ZC) caused the same amount 
of histamine  release  (Fig.  3).  The zymosan and  plasma  together, however, 
showed an increasing inhibition of release. 
Table  III  shows  the  inhibitory effect of  supernatants  from zymosan,  or 
BSA and anti-BSA incubated with plasma for 30 min at 37°C. The supernatant 
from zymosan and plasma was inhibitory to histamine release induced by both 
zymosan and by BSA-anti-BSA. Inhibitor was also produced by the soluble 
antigen-antibody  system  and  slightly  more  was  produced  by  antigen  and 
•  Washed before addition of platalets 
o Not washed 
60- 
5C 
~-  40- 
.E 
~  30- 
"~  20- 
a.  10- 
Minutes ef Preincubation  with Plasma 
FIo. 3.  Generation of an inhibitor of histamine release. Platelets (2.5 X  10  s) were added to 
zymosan (2.5 X 108)  which had been preincubated  with the plasma or to zymosan which had 
been preincubated and then washed. Histamine release was assayed after 30 min incubation 
with platelets at 37  ° C. 
antibody at equivalence than in antibody excess. In each case the amount of 
inhibition  generated  in  the  plasma  increased  with  the  time  of  incubation. 
No inhibitory activity was found in the supematant from zymosan plus EDTA- 
plasma. 
It had previously been noted that even with antigen and antibody at equiva- 
lence, a  situation which might be expected to resemble more closely the par- 
ticulate  antigen  system,  C6-deficient  plasma  did  not  support  histamine 
release.  Plasma  from  three  homozygous,  C6-deficient rabbits  was  therefore 
compared  with  plasma  from heterozygous siblings  to  see  if  there  was  any 
difference in  the  quantity  of  inhibitor  generated.  It  was  found  that  more 
inhibitor was generated in the C6-deficient plasma (Table III). 
The Requirement for Calcium.--Chelation  of divalent cations prevents the 176  HISTAMINE RELEASE FROM RABBIT PLATELETS. II 
release of histamine from platelets by the soluble antigen  system. In an  at- 
tempt  to  characterize  the  cation  required for  release  by  antigen,  antibody 
and plasma. Siraganian,  Secchi, and Osler (18)  showed that addition of mag- 
nesium  to  EDTA-plasma  was  sufficient  to  restore  the  releasing  activity. 
As complement requires calcium for the activation of C1, the present system 
was examined for the  effect of  chelating  agents.  Ethylene  glycol tetraacetic 
acid (EGTA) was employed because it has a higher binding affinity for calcium 
than does EDTA. 
TABLE III 
Generation of an Inhibitor  of Platelet Histcmine Release from Plasma 
Inhibitor-generating  system* 
~g +  Ab +  plasma (antibody excess) 
~g +  Ab +  plasma (equivalence) 
~g +  Ab +  C6-def plasma (equivalence) 
Histamine-releasing 
system 
Ag +  Ab + 









+  plasma 
Plasma alone 
D 
+  plasma 
+  C6-def plasma 
+  EDTA plasma 
Plasma alone 
excess)~ 






















* The reactants  were incubated at 37°C for 30 min, centrifuged, and  the  supematant 
added to the histamine-releasing system. Antibody, 10/~g N; antigen, 0.1 #g N  (antibody 
excess) and 2 #g N (equivalence);  zymosan, 2.5 X 10  s particles; plasma, 0.25 ml. 
~: Antibody (10 #g N) +  antigen (0.1 #g N) +  0.25 ml (10%) plasma. The histamine 
release was assayed after 30 rain at 37°C. 
§ Zymosan (2.5 X l0  s particles) incubated with 0.25 ml plasma and then washed. 
These results are representative of those from three similar experiments. 
Calcium chloride, magnesium chloride, or a  combination of both was added 
at different  concentrations  to  a  BSA-anti-BSA system which  had been pre- 
vented from releasing histamine by the presence of EGTA. In addition to ex, 
amining platelet  clumping and histamine release,  identical  tubes were set up 
in  which  sensitized  sheep  erythrocytes  (EA)  replaced  the platelets,  antigen, 
and antibody. This was done in order to assess the hemolytic activity of the 
complement under  these  conditions.  The results  are presented  in Table IV. 
If  10%  plasma was  used,  addition  of magnesium  alone  was  sufficient  to 
restore  some hemolytic, platelet  clumping,  and" histamine-releasing  activity, 
possibly because of insufficient  binding  of  calcium at  this  high  plasma con- •  ~. ~z KENSON AND  c.  o,  COCHRAN'E  177 
centration. Addition of calcium, on the other hand, permitted more hemolysis 
and histamine release. If 4% plasma was employed, the different effect of the 
TABLE IV 
Cation Requirement/or ttistam~¢ Release* 
Plasma 
4% plasma +  4 X  10  4  x 
EGTA 
10% plasma +  5  X  10  -~ M 
EGTA 
Molarity X lO-q 
Ca++  MS++ 
12 
--  12 
8  4 
10 
--  10 
































* Histamine release from 2.5 X  10  s platelets was produced by addition of 10 #g Ab N, 
0.1 /~g Ag N in the presence of 4 or 10% rabbit plasma. Platelet clumping was observed 
microscopically. Duplicate tubes contained 2.5 X  10  7 sensitized sheep erythrocytes instead 
of Ag and Ab. 
Final molar concentration in the reaction mixture. 
TABLE V 
The Effect of Hirudin on Platdel Histamine Rdease 
Releasing  syste~n 
Thrombin (0.05 units) 
Ag +  Ab +  plasma (antibody 
excess) * 
Washed ZC* 




















* The histamine-releasing systems are described in Table III. 
two cations was clarified. Addition of magnesium was not capable of restoring 
the platelet dumping or histamine-releasing activity, although a small amount 
of hemolysis was observed. On the other hand, clumping, histamine release, 
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a/finities, excess calcium will release bound magnesium so that in this latter 
circumstance both free calcium and magnesium may be expected to be present. 
Addition of both cations resulted in increased release. The results indicate a 
requirement for calcium  and possibly  magnesium as well, in  the histamine 
release process. 
Demonstration  That  the  Release Is  Not  Due  to  the  Action  of  Thrombin.-- 
Small quantities of thrombin will cause platelet histamine release. To exclude 
an action of thrombin in the in vitro release mechanism  involving  antigen, 
antibody, and complement,  the inhibitory action of heparin and hirudin was 
examined. Table V shows that hirudin was 10,000 times more effective as an 
inhibitor of histamine release by thrombin than as an inhibitor of the immuno- 
logical systems. Heparin also showed a wide difference, but was inhibitory to 
complement  at high concentrations. 
DISCUSSION 
The release of histamine from platelets induced by homologous antibody and 
an antigen unreleated to the platelet could be shown to result from two dif- 
ferent mechanisms,  one involving particulate and the other soluble antigens. 
Both mechanisms required the participation of complement. 
Particulate Antigens.--Zymosan and erythrocytes which had fixed comple- 
ment (ZC and EAC) could be washed and then reacted with the platelets in a 
plasma-free  environment. Platelets adhered to the ZC or EAC particles  and 
histamine was released into the medium. This reaction required  the participa- 
tion of complement components only through C3 or perhaps C5 in the sequence, 
since zymosan or EA treated with C6-deficient plasma was fully active.  The 
reaction did not take place when platelets were exposed to EAC1,4,2. Only 
after the addition of C3 did the platelets adhere and release their histamine. 
The immune adherence of platelets from certain species has been described 
previously (12, 13)  and the requirements  for adherence  herein  reported con- 
firm these results. The present studies further these findings by demonstrating 
that the  adherence  reaction of platelets with a  particulate antigen induces 
release of histamine. This release may l~e associated with platelet degranulation 
similar  to that described by Spielvogel (8)  for the reaction of platelets with 
endotoxin. 
A number of possible mechanisms  were  examined  that could  explain  the 
release of histamine once the platelet was adherent to the particle. It is possible 
that following adherence,  which  required  fixed C3,  other complement com- 
ponents could act on the platelets which have now been brought into contact 
with the complex. Any effect of C1  or C2 in this way was rendered unlikely 
by the observation that the releasing action of ZC did not decay after incuba- 
tion in the presence of EDTA followed by washing. C3 peptidase activity (19) 
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the  inabifity  of  a  substrate  of  the  enzyme  (glycyl-tyrosine)  to  inhibit  the 
activity suggest that this enzyme is not responsible.  Because it was not pos- 
sible to separate completely the rabbit C3 from contaminating C5, an action of 
this  latter  component  cannot  be  completely  ruled  out,  although  rendered 
unlikely by the decay experiments. Another possibility, that  the known his- 
tamine-releasing  action  of  anaphylatoxins  on  mast  cells  might  also  affect 
platelets, is not easily reconcilable  with the inability of anaphylatoxins to act 
on platelets directly. Furthermore,  histamine  was released from platelets by 
washed ZC which would have little or no anaphylatoxin activity. The release 
was in all probability not induced by thrombin because the action of thrombin 
on platelets was inhibited by small quantities of hirudin, whereas even 10,000 
fold  larger  quantities  of  this  substance  were  not  inhibitory  to  the  action 
of ZC. 
A remaining  hypothesis involves the adherence process itself. It is suggested 
that a reaction of platelets with the C3 (or perhaps ~,-globulin or C4)  spread 
out along the surface of a particle itself  triggers off a  release  reaction in the 
platelet. This release  reaction has received some additional study, and it has 
become apparent  that  an  active participation  of  the platelet is required,  as 
release  of  histamine  is  blocked  in  the  absence  of  energy metabolism  and 
when certain platelet esterases are inhibited.  2 
This  release  reaction  of  the  platelet  may have  some protective  function 
perhaps related to the body's defence against foreign invaders.  By adhering 
to the foreign particles and releasing constituents, greater amounts of antibody 
and complement would be brought into the site. Only platelets from certain 
species  undergo  adherence  reactions with  complement  (13).  However, those 
from at least two of the nonreacting species, man and the pig,  do react with 
antigen-antibody complexes (20). Thus the mechanism of release may be simi- 
lar although the stimulus (adherence)  is caused by different substances. 
Soluble Antigens.--The reaction of soluble antigen,  antibody, and platelets 
in the presence of plasma, resulted in platelet clumping.  In conditions of anti- 
body  excess  these  clumps  were  not  large  and  antigen-antibody  complexes 
were not visible.  At equivalence,  platelets were caught up in the precipitate. 
Inhibition of this clumping by inactivation or absorption of complement or by 
depletion of C3 suggested that  this too was a  manifestation  of the immune 
adherence reaction. The small size of the platelet clumps presumably resulted 
from the condition of antibody excess. Because of platelet lysis,  the clumps 
were more difficult  to see with increasing  incubation time.  Gocke and Osier 
(7) did not observe much clumping but looked later in the reaction. Moreover, 
under their more dilute condition, small  complexes may have adhered to the 
platelets without producing so much cross-linking. 
The clumping of platelets with nonparticulate antigens in the complex was 
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not by itself sufficient to cause release of histamine. This was shown by the 
use  of  C6-deficient  plasma,  which  produced  clumping  but  not  histamine 
release. Addition of C6 restored  the releasing activity and thus demonstrated 
that a soluble antigen system, unlike that with a particulate antigen,  required 
later-acting complement components. The evidence for complement participa- 
tion provided by these studies extends the results of Humphrey and ~acques 
(5)  and of  Gocke  (11) who presented evidence  that hemolytic complement 
was involved. Siraganian,  Secchi, and Osler (18) demonstrated a requirement 
for magnesium. While a similar requirement was observed in the present study, 
it has been shown that calcium is needed  as well, a finding that agrees with 
previous  reports (5). This is entirely in accord with the known requirements 
for divalent cations in the complement system. 
Since  the  antibody of  the  immune  complex  is  not  directed  against  the 
platelet, the mechanism by which the later-acting components  of complement 
induce the release is perplexing. A possible, but as yet unproven, mechanism 
is  that close contact or  even  phagocytosis  of very small  complexes in  the 
presence of the total complement sequence might result in a lyric action of the 
complement on the cell membrane,  even though the antigen is not a part of 
that membrane. An alternate hypothesis involves  an  action  of the C5-6-7 
complex, a substance  which is known to activate certain neutrophil enzymes 
(21). 
One  of  the difficulties with the hypothesis of complement  action is  that 
maximal  histamine  release  occurs  with  antibody excess, whereas  maximal 
complement fixation occurs at equivalence. Such determinations, however, are 
based  on the inactivation of complement  for hemolysis.  On the other hand, 
the binding of platelets in  immune adherence  occurs  as  a  function of the 
availability of bound C3.  This may well be greater in the antibody excess 
condition where less bound C3 would be internalized in the complex. Evidence 
for the importance of the size and structure of the complex came  from the 
finding that preincubation of antigen and antibody in antibody excess, before 
addition of plasma and platelets,  resulted in less histamine release. At equiva- 
lence there was no such reduction in releasing activity due to preincubation 
without plasma.  This suggests  that a  configurational  change  occurs in com- 
plexes  in  antibody  excess with  preincubation  which  results  in  diminished 
activity. The results differ somewhat from those of Gocke and Osier (7), but 
may reflect  different conditions  of preincubation. The reduction of activity 
following preincubation of antigen and excess antibody may account,  in part, 
for the much greater loss of activity seen if antigen, antibody, and plasma 
were incubated together before addition of platelets. 
Generation of an Inhibitor of Histamine Release.--Prior reaction of the anti- 
gen, antibody, and plasma produces an inhibitor of the release reaction when 
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lease mechanisms  discussed in  this  paper.  Since it was  inhibitory to  the re- 
lease  induced by ZC,  it  did not  appear  to work  by preventing complement 
fixation. Its generation was found to require divalent cations. More inhibitor 
was generated in  C6-deficient plasma  than in normal plasma,  but this would 
not account for the inability of C6-deficient plasma  to support the release of 
histamine  from  platelets  when  a  soluble  antigen  was  employed,  since  the 
addition of C6 restored the releasing activity of the plasma. The exact nature 
of this  inhibitor is  as  yet undetermined,  but its production apparently  con- 
tributes to the decay of activity observed after preincubation of antigen, anti- 
body, and plasma. 
Generation  of  a  substance  into  the  surrounding  medium  from  antigen- 
antibody-complement interaction which  causes histamine  release from plate- 
lets has not,  therefore, been demonstrated. The release processes seem to re- 
quire adherence of the platelet to the complex. 
In  Vitro  Histamine Release by Complement-dependent PCA  Antibody.--This 
antibody, which has been described previously (1), was capable of causing in 
vitro histamine release from platelets. This process may, therefore, account for 
the in vivo findings  that platelets  and histamine  participate in  the PCA  re- 
action. The reaction of complexes with platelets in  these lesions may involve 
one or both of the release mechanisms described herein as both are inhibited 
by  cobra venom factor.  Following  the  initial  reaction  of  antigen,  antibody, 
complement,  and  platelets,  release  of  platelet  ADP  could  further  produce 
aggregation  of platelets,  thus  serving  to  potentiate  any  effect. In  addition, 
there  may  also  be  other  as  yet undefined  processes  that  are  operative.  In 
particular, recent observations have indicated a synergistic action of neutrophils 
on the release of histamine from platelets in the presence of immune complexes 
and complement  .2 
SUMMARY 
Two mechanisms have been described whereby rabbit platelets in vitro may 
be induced to release their contained histamine by the reaction of antigen and 
antibody. Both processes require the participation of the complement system. 
In the first, the adherence of platelets to particulate antigens such as zymosan 
or  erythrocytes which  have fixed complement through  the  third  component 
was followed by histamine release. Plasma lacking C6 activity was fully active 
in this system. 
In the second mechanism,  the reaction of soluble antigen with antibody in 
the  presence  of plasma  also  caused  release  of histamine  from platelets  and 
platelet clumping was observed. The release process, which appeared to follow 
the adherence of platelets to the immune complex, required the action of C6 and 
perhaps  the  later-acting components. No  evidence could be  obtained  that  a 
soluble  factor was  produced which  caused  the  release.  Instead,  an  inhibitor 182  HISTAMINE  RELEASE  FROM  RABBIT  PLATELETS.  II 
of  the  release  process  was  detected  after  incubation  of  antigen,  antibody, 
and plasma. 
Antibody  preparations  capable  of  giving  complement-dependent  PCA 
reactions in  rabbits were  also  shown  to  induce  the  release of histamine from 
platelets in vitro. 
The  authors  are grateful  to Mr. G. M. Standford for preparing the illustrations. 
BIBLIOGRAPHY 
1.  Henson, P.M. and  C. G. Cochrane.  1969. Immunological induction of increased 
vascular permeability. I. A rabbit PCA reaction requiring complement, platelets 
and neutrophils. J. Exp. Med.  19.9:153. 
2.  Henson, P., and C. Cochrane. 1968. Complement dependent release of histamine 
from  rabbit platelets by antigen-antibody reactions. Fed. Proc.  9.I:479. 
3.  Cochrane, C. G., D. Hawkins, and W. T. Kniker. 1967. Mechanisms involved in 
the localization of circulating immune complexes in blood vessels. In  Immuno 
pathology. V. P. Miescher and P. Grabar, editors. Schwabe and Co., Basel. 32. 
4.  Cochrane, C. G., and W. T. Kniker. 1968. The localization of circulating immune 
complexes in experimental serum sickness. The role of vasoactive amines and 
hydrodynamic forces. J. Exp. Med. 127:119. 
5.  Humphrey, J. H., and R. Jaques.  1955. The release of histamine and 5-hydroxy- 
tryptamine (serotonin) from platelets by antigen-antibody reactions  (in vitro). 
J. Physiol. (London) 128:9. 
6.  Barbaro, J.  F.  1961. The release of histamine from rabbit platelets by means of 
antigen-antibody precipitates. I. The participation of the immune complex in 
histamine release. J. Immunol. 86:369. 
7.  Gocke, D. J., and A. G. Osler. 1965. In vitro damage of rabbit platelets by an un- 
related-antibody reaction. I. General characteristics of the reaction. J. Immunol. 
94:236. 
8.  Spielvogel, A. R.  1967. An ultrastructural study of the mechanisms of platelet- 
endotoxin interaction. J. Exp. Med. 19.6:235. 
9.  Bryant, R., and R. Des Prez. 1968. Mechanisms of immunologically-induced rab- 
bit platelet injury. Clin.  Res. 16: 318. 
10.  Barbaro~ J.  F.  1961. The release of histamine from rabbit platelets by means of 
antigen antibody precipitates. II. The role of plasma in the release of histamine. 
J.  Immunol. 86:  377. 
11.  Gocke, D. J.  1965. In vitro damage of rabbit platelets by an unrelated antigen- 
antibody reaction. II. Studies of the plasma requirement, ft. Immunol. 94" 247. 
12.  Siqueira, M., and R. A. Nelson. 1961. Platelet agglutination by immune complexes 
and its possible role in hypersensitivity. J. ImmunoI. 86: 516. 
13.  Henson, P. M.  1969. The adherence of leucocytes and platelets induced by fixed 
IgG antibody or complement.  Immunology.  16:  107. 
14.  Kabat, E. A., and M. M. Mayer. 1961. Experimental Immunochemistry. Charles 
C Thomas, Springfield, Ill. 22. 
15.  Ni]sson, U., and H. J. Mfiller-Eberhard. 1965. Isolation of fllF-globulin from hu- 
man  serum  and  its  characterization as  the  fifth  component  of  complement. 
J. Exp. Med. 129.: 277. P.  M.  HENSON  AND  C.  G.  COCHRANE  183 
16.  Linscott, W. D., and C. G. Cochrane. 1964. Guinea pig B1C-globulin: Its relation- 
ship to the third component of complement and its alteration following inter- 
action with immune complexes. J. Immunol. 93: 972. 
17.  Siraganian, R. P., and B. Oliviera.  1968. The allergic  response of rabbit platelets 
and leukocytes. Fed. Proc. 27: 315. 
18.  Siraganian, R. P.,  A.  G.  Secchi,  and A.  G.  Osier.  1968. Histamine release  from 
rabbit  platelets--Mechanism  of the  allergic  response.  In International  Sym- 
posium on the Biochemistry of the Acute Allergic Reactions. K. F. Austen  and 
E. L. Becker, editors. Blackwell Scientific  Publications Ltd., Oxford,  England. 
In press. 
19.  Cooper, N. R., and E. L. Becket. 1967. Complement associated peptidase activity 
of guinea-pig serum. I. Role of complement components. J. ImmunoI. 98: 119. 
20.  Movat, H. Z.,  J. F. Mustard,  N. S. Taichman, and T. Uriuhara.  1965. Platelet 
aggregation  and  release  of  ADP,  serotonin  and  histamine  associated  with 
phagocytosis of antigen-antibody complexes. Proc. Soc. Exp. Biol. Med. 120: 232. 
21.  Ward, P. A., and E. L. Becker. 1967 Mechanisms of the inhibition of chemotaxis 
by phosphonate esters. J. Exp. Med. 125: 1001. lSAx  HISTAMINE  RELEASE  FROM  RABBIT  PLATELETS.  II 
FIG. 4.  Clumping of platelets by antigen and antibody in the presence of plasma. 
a. Antigen, plasma, and platelets, b. Antigen,  antibody, plasma, and platelets (Note 
clumping of platelets). See Table I for details. 